These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 34547850)
41. Knowledge and Practice of Health Care Workers regarding Needle Stick Injuries in a Tertiary Care Center of Nepal. Singh B; Paudel B; Kc S Kathmandu Univ Med J (KUMJ); 2015; 13(51):230-3. PubMed ID: 27180369 [TBL] [Abstract][Full Text] [Related]
42. Q-Switched Neodymium-Doped Yttrium Aluminum Garnet laser therapy for pigmented skin lesions: efficacy and safety. Karn D; K C S; Amatya A; Razouria EA; Timalsina M; Suwal A Kathmandu Univ Med J (KUMJ); 2012; 10(38):46-50. PubMed ID: 23132475 [TBL] [Abstract][Full Text] [Related]
43. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [TBL] [Abstract][Full Text] [Related]
44. Self-reported health and sleep complaints among nursing personnel working under 12 h night and day shifts. Portela LF; Rotenberg L; Waissmann W Chronobiol Int; 2004; 21(6):859-70. PubMed ID: 15646233 [TBL] [Abstract][Full Text] [Related]
45. Randomized clinical trial of facial acupuncture with or without body acupuncture for treatment of melasma. Rerksuppaphol L; Charoenpong T; Rerksuppaphol S Complement Ther Clin Pract; 2016 Feb; 22():1-7. PubMed ID: 26850796 [TBL] [Abstract][Full Text] [Related]
46. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial. Adalatkhah H; Sadeghi-Bazargani H Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129 [TBL] [Abstract][Full Text] [Related]
47. Epidemiology of melasma in Brazilian patients: a multicenter study. Hexsel D; Lacerda DA; Cavalcante AS; Machado Filho CA; Kalil CL; Ayres EL; Azulay-Abulafia L; Weber MB; Serra MS; Lopes NF; Cestari TF Int J Dermatol; 2014 Apr; 53(4):440-4. PubMed ID: 23967822 [TBL] [Abstract][Full Text] [Related]
48. Prevalence of Hospital Acquired Infection and its Preventive Practices among Health Workers in a Tertiary Care Hospital. Shrestha PD; Rai S; Gaihre S J Nepal Health Res Counc; 2019 Jan; 16(41):452-456. PubMed ID: 30739939 [TBL] [Abstract][Full Text] [Related]
50. A Randomized, Controlled, Split-Face Study of the Efficacy of a Picosecond Laser in the Treatment of Melasma. Lyons AB; Moy RL; Herrmann JL J Drugs Dermatol; 2019 Nov; 18(11):1104-1107. PubMed ID: 31741350 [TBL] [Abstract][Full Text] [Related]
51. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Javaheri SM; Handa S; Kaur I; Kumar B Int J Dermatol; 2001 May; 40(5):354-7. PubMed ID: 11555002 [TBL] [Abstract][Full Text] [Related]
52. New Protocol for Long-Term Results With a Multi-Pulse Nd:YAG Laser for Melasma Treatment: A Descriptive Cohort Study. Ocampo JCV; Ocampo SV; Vélez NC; Braun M J Drugs Dermatol; 2021 Feb; 20(2):150-154. PubMed ID: 33538564 [TBL] [Abstract][Full Text] [Related]
53. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study. Lima EVA; Lima MMDA; Paixão MP; Miot HA BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309 [TBL] [Abstract][Full Text] [Related]
54. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Castanedo-Cazares JP; Hernandez-Blanco D; Carlos-Ortega B; Fuentes-Ahumada C; Torres-Álvarez B Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):35-42. PubMed ID: 24313385 [TBL] [Abstract][Full Text] [Related]
55. Extra-facial melasma: clinical, histopathological, and immunohistochemical case-control study. Ritter CG; Fiss DV; Borges da Costa JA; de Carvalho RR; Bauermann G; Cestari TF J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1088-94. PubMed ID: 22827850 [TBL] [Abstract][Full Text] [Related]
56. Topical liquiritin improves melasma. Amer M; Metwalli M Int J Dermatol; 2000 Apr; 39(4):299-301. PubMed ID: 10809983 [TBL] [Abstract][Full Text] [Related]
57. Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up. Lueangarun S; Sirithanabadeekul P; Wongwicharn P; Namboonlue C; Pacharapakornpong S; Juntongjin P; Tempark T J Clin Aesthet Dermatol; 2020 Aug; 13(8):36-39. PubMed ID: 33178380 [No Abstract] [Full Text] [Related]
58. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574 [TBL] [Abstract][Full Text] [Related]
59. Knowledge, Attitude, and Practices Related to COVID-19 among Healthcare Personnel in a Tertiary Care Hospital in Nepal: A Cross-sectional Survey. Basnet S; Dahal S; Tamrakar D; Shakya YR; Jacobson C; Shrestha J; Shrestha SK Kathmandu Univ Med J (KUMJ); 2020 COVID-19 SPECIAL ISSUE; 18(70):21-28. PubMed ID: 33605234 [TBL] [Abstract][Full Text] [Related]
60. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma. Basit A; Rahman A; Uddin R J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]